Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in venous thrombotic disease.

British journal of haematology - 1 Dec 1998

Franco R F, Maffei F H, Lourenço D, Morelli V, Thomazini I A, Piccinato C E, Tavella M H, Zago M A

Abstract excerpt

We investigated the prevalence of two reported mutations of the factor V gene (factor V Arg306-->Thr, or factor V Cambridge, and factor V Arg306-->Gly) in 104 relatively young patients with verified venous thrombosis and in 208 age-, sex- and race-matched controls, in order to establish whether the two mutations are associated with increased predisposition for venous thrombosis. PCR amplification followed by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Amino Acid Substitution

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Genetic Predisposition to Disease

Share to Infant

Share to Mutation

Share to Risk Factors

Source

Identifiers

PMID: 9858251
DOI: 10.1046/j.1365-2141.1998.01051.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in venous thrombotic disease.PMID 9858251Read ↗

Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein C.Semantic proximity Read ↗

Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis.Semantic proximity Read ↗

Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.Semantic proximity Read ↗

Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease.Semantic proximity Read ↗

Detection of a common mutation in factor V gene responsible for resistance to activate protein C causing predisposition to thrombosis.Semantic proximity Read ↗

Mutations at the activated protein C cleavage sites Arg336 and Arg562 of factor VIII in Thai patients with venous thrombosis.Semantic proximity Read ↗

Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.Semantic proximity Read ↗

Molecular detection of a common mutation in coagulation factor V causing thrombosis via hereditary resistance to activated protein C.Semantic proximity Read ↗

Prevalence of Factor V Genetic Variants Associated With Indian APCR Contributing to Thrombotic Risk.Semantic proximity Read ↗

Homozygous factor V splice site mutation associated with severe factor V deficiency.Semantic proximity Read ↗

Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai populationSemantic proximity Read ↗

Three novel mutations in the protein C (PROC) gene causing venous thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.